ARS Pharmaceuticals initiated with an Outperform at Oppenheimer
Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved ...
MarketWatch6d
Supernus Pharmaceuticals Inc.
Copyright © 2025 MarketWatch, Inc. All rights reserved.
The Globe and Mail6d
Parkinson’s Disease Market is anticipated to Grow at a CAGR of 5.8% During the Study Period (2020-2034) by DelveInsight
Parkinson’s Disease Companies are UCB Biopharma SRL, Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma, NeuroDerm ...
Yahoo Finance6d
Supernus Pharmaceuticals, Inc. (SUPN)
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Stock Traders Daily5d
How the (SUPN) price action is used to our Advantage
Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.
MarketWatch1d
Madrigal Pharmaceuticals Inc.
Infinity Pharmaceuticals Inc. 0.00% $90.76 ...
Yahoo Finance6d
Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts
In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare ...
Business Wire6d
Crown Laboratories Completes Acquisition of Revance Therapeutics
The "Crown" logo, PanOxyl and Blue Lizard are registered trademarks of Crown Laboratories, Inc. SkinPen and StriVectin are registered trademarks of Bellus Medical, LLC and StriVectin Operating Company ...